Skip to content
healthcare.dev
Get a free key

ACTEMRA

NDC 50242-135, tocilizumab, injection, solution, concentrate, from Genentech, Inc..

Product NDC
50242-135
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125276
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-135 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOCILIZUMAB80 mg/4mL

Pharmacologic classes

Interleukin 6 Receptor Antagonists [MoA]; Interleukin-6 Receptor Antagonist [EPC]

Package NDCNDC-11Package
50242-135-01502420135011 VIAL, SINGLE-USE in 1 BOX (50242-135-01) / 4 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-135

Use it

Look up 50242-135 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-135 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.